scholarly article | Q13442814 |
P2093 | author name string | Nagai R | |
Nakamura K | |||
Kuro-o M | |||
Manabe N | |||
Chikuda H | |||
Kawaguchi H | |||
Miyaura C | |||
Inada M | |||
Sinclair AM | |||
Scheuermann RH | |||
Nabeshima Y | |||
P2860 | cites work | Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 | Q22010683 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2625-2631 | |
P577 | publication date | 2001-09-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Connection between B lymphocyte and osteoclast differentiation pathways. | |
P478 | volume | 167 |
Q35019456 | A new hypothesis for how sex steroid hormones regulate bone mass |
Q53190419 | Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG. |
Q54684809 | Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1. |
Q33213751 | Areca nut extracts modulated expression of alkaline phosphatase and receptor activator of nuclear factor kappaB ligand in osteoblasts |
Q41845836 | Autocrine signaling is a key regulatory element during osteoclastogenesis. |
Q35804512 | B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo |
Q36324944 | B cells and osteoblast and osteoclast development |
Q59795892 | B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation |
Q52026400 | B cells play an important role in lipopolysaccharide-induced bone resorption. |
Q28066397 | Bone Cells Dynamics during Peri-Implantitis: a Theoretical Analysis |
Q44794499 | Bone mineral density in systemic lupus erythematosus women one year after rituximab therapy |
Q52911552 | Cellular composition of the initial fracture hematoma compared to a muscle hematoma: a study in sheep. |
Q58799794 | Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study |
Q47397479 | Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice. |
Q34513670 | Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian women. |
Q44509153 | Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice |
Q34576622 | Estrogen deficiency and bone loss: an inflammatory tale |
Q46596392 | Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis in mice |
Q46471465 | Expression of receptor activator of nuclear factor kappaB ligand in ligature-induced periodontitis in osteoporotic and non-osteoporotic rats |
Q33635563 | Fracture healing is accelerated in the absence of the adaptive immune system. |
Q54644133 | Functional osteoclast-like transformation of cultured human myeloma cell lines. |
Q39615657 | Hematopoietic Stem Cells in Neural-crest Derived Bone Marrow. |
Q28591227 | IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells |
Q37172761 | In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis |
Q98465839 | Inflammatory response in postmenopausal osteoporotic fracture healing |
Q51813167 | Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-γ possibly induced from non-T cell population |
Q88680129 | Integration of summary data from GWAS and eQTL studies identified novel causal BMD genes with functional predictions |
Q58419491 | Interactions Between Multipotential Stromal Cells (MSCs) and Immune Cells During Bone Healing |
Q35825391 | Interactions between the immune system and bone. |
Q34705704 | Microarray analysis of nicotine-induced changes in gene expression in a macrophage-like human cell line |
Q36013609 | Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors |
Q36661654 | Molecular backgrounds of age-related osteoporosis from mouse genetics approaches |
Q92853434 | Multiple Modes of Vitamin K Actions in Aging-Related Musculoskeletal Disorders |
Q40538587 | Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation. |
Q52317346 | Niches for Hematopoietic Stem Cells and Their Progeny. |
Q81163085 | No mixing of granulocytes and other lymphocytes in the inflamed joints of parabiosis mice with collagen-induced arthritis: possible in situ generation |
Q35992094 | Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice |
Q54520688 | Osteoclast differentiation by human osteoblastic cell line SaOS-2 primed with bacterial lipid A. |
Q47722850 | Osteoclast-like cell formation by circulating myeloma B lymphocytes: role of RANK-L. |
Q37808649 | Osteoclastogenesis and arthritis |
Q89820667 | Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System |
Q47944184 | Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. |
Q36942525 | Osteoimmunology: a view from the bone |
Q24655113 | Osteoimmunology: interactions of the bone and immune system |
Q27329714 | Osteoprotegerin in bone metastases: mathematical solution to the puzzle |
Q53510692 | Ovariectomy-induced bone loss occurs independently of B cells. |
Q99557259 | PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling |
Q36602669 | Periodontal disease and systemic conditions: a bidirectional relationship. |
Q28252713 | Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease |
Q53581241 | Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. |
Q48039377 | RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice |
Q35551233 | Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis |
Q36216058 | Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss |
Q37884121 | Regulation of bone by the adaptive immune system in arthritis |
Q37172756 | Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone |
Q36324952 | Role of interleukin-7 in bone and T-cell homeostasis |
Q36559431 | Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis |
Q34566395 | Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells |
Q84229582 | Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis |
Q35750903 | Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging |
Q37052226 | The Interplay between the bone and the immune system |
Q37287589 | The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis |
Q91611014 | The Role of Macrophage in the Pathogenesis of Osteoporosis |
Q47104734 | The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases |
Q52366183 | The Role of the Immune Cells in Fracture Healing. |
Q37044693 | The burden of rheumatoid arthritis and access to treatment: a medical overview |
Q28585699 | The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization |
Q34143343 | The immune system and bone |
Q36324949 | The role of T lymphocytes in bone metabolism |
Q36324969 | The role of the immune system in the pathophysiology of osteoporosis |
Q44480297 | The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors |
Q64102242 | Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System |
Q42489674 | Vitamin E suppresses ex vivo osteoclastogenesis in ovariectomized rats |
Search more.